Fulgent Genetics, Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
2
Ending by 2030
Dec 2026
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 2 fees due Apr 29 to 30, 2027 · next Apr 29
- 1 fee due Nov 3, 2027The maintenance fee for Immunogenicity Assay (US 9,329,187) comes due Nov 3, 2027. Unpaid by May 3, 2028, it lapses early.
Recent changes
- 1 term has ended since Aug 17, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US D672,053 | Multi-lateral flow assay strip carrier assembly In force · From the USPTO record | In force | From the USPTO record | |
| US 9,329,187 | Immunogenicity Assay In force · From the USPTO record | In force | From the USPTO record | |
| US 10,274,501 | Immunogenicity Assay In force · Medium confidence | In force | Medium confidence | |
| US 10,688,048 | Hydrophobic molecule-induced branched polymer aggregates and their use In force · From the USPTO record | In force | From the USPTO record | |
| US 12,042,561 | Hydrophobic molecule-induced branched polymer aggregates and their use In force · From the USPTO record | In force | From the USPTO record | |
| US 9,944,755 | Oxazoline polymer compositions and use thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 10,458,916 | Rapid tests for the detection of inhibitors of enzymes and human exposure to the same In force · From the USPTO record | In force | From the USPTO record | |
| US 9,850,522 | One-step rapid assay for the detection of inhibitors of enzymes In force · From the USPTO record | In force | From the USPTO record | |
| US 12,396,962 | Nanoparticles containing a taxane and their use In force · From the USPTO record | In force | From the USPTO record | |
| US 11,801,230 | Nanoparticles containing a taxane and their use In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 14: 6 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 pending · 1 abandoned · 1 no status recorded